Andreia C. De Melo

Rio De Janeiro, RJ, Brazil

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 135 publications

Response to comments by Muskaan and colleagues on the article "In vivo dosimetry in patients undergoing radiotherapy for head and neck cancer using an intraoral stent: a prospective cohort".

Response to comments by Muskaan and colleagues on the article "In vivo dosimetry in patients undergoing radiotherapy for head and neck cancer using an intraoral stent: a prospective cohort".

Journal: Oral surgery, oral medicine, oral pathology and oral radiology

Published: June 17, 2026

Cytokine and Lymphocyte Profiles in COVID-19 Patients with Cancer: Implications for Disease Severity and Clinical Outcomes.

Cytokine and Lymphocyte Profiles in COVID-19 Patients with Cancer: Implications for Disease Severity and Clinical Outcomes.

Journal: Viruses

Published: April 29, 2026

Ovarian cancer global trends and disparities across 204 countries and territories.

Ovarian cancer global trends and disparities across 204 countries and territories.

Journal: Gynecologic oncology

Published: March 05, 2026

The changing landscape of oncology clinical trials in Latin America.

The changing landscape of oncology clinical trials in Latin America.

Journal: Nature reviews. Clinical oncology

Published: March 04, 2026

EGFR and PGE2 signaling pathways mutually cooperate to promote pro-tumorigenic effects in cervical cancer.

EGFR and PGE2 signaling pathways mutually cooperate to promote pro-tumorigenic effects in cervical cancer.

Journal: Biochimica et biophysica acta. Molecular basis of disease

Published: March 02, 2026

Oral selective estrogen receptor degraders in hormone receptor-positive, HER2-negative advanced breast cancer: a systematic review and meta-analysis.

Oral selective estrogen receptor degraders in hormone receptor-positive, HER2-negative advanced breast cancer: a systematic review and meta-analysis.

Journal: Breast cancer research and treatment

Published: February 21, 2026

Epidemiology of Cervical Cancer in Brazil: Age-Specific Trends From 2000 to 2018.

Epidemiology of Cervical Cancer in Brazil: Age-Specific Trends From 2000 to 2018.

Journal: JCO global oncology

Published: February 20, 2026

Cancer in Pregnancy: Therapeutic Decisions at the Intersection of Two Lives.

Cancer in Pregnancy: Therapeutic Decisions at the Intersection of Two Lives.

Journal: Diagnostics (Basel, Switzerland)

Published: February 07, 2026

Pembrolizumab plus weekly paclitaxel in platinum-resistant recurrent ovarian cancer (ENGOT-ov65/KEYNOTE-B96): a multicentre, randomised, double-blind, phase 3 study.

Pembrolizumab plus weekly paclitaxel in platinum-resistant recurrent ovarian cancer (ENGOT-ov65/KEYNOTE-B96): a multicentre, randomised, double-blind, phase 3 study.

Journal: Lancet (London, England)

Published: February 04, 2026

Do ethnic differences influence the response to immunotherapy in advanced cervical cancer?

Do ethnic differences influence the response to immunotherapy in advanced cervical cancer?

Journal: Translational cancer research

Published: January 25, 2026

Social inequities and clinical outcomes in young women with cervical cancer: Real-world evidence.

Social inequities and clinical outcomes in young women with cervical cancer: Real-world evidence.

Journal: PloS one

Published: December 23, 2025

Biomarker heterogeneity and efficacy of durvalumab plus carboplatin/paclitaxel followed by durvalumab with or without olaparib in patients with mismatch repair proficient endometrial cancer: exploratory analyses of the DUO-E/GOG-3041/ENGOT-EN10 trial.

Biomarker heterogeneity and efficacy of durvalumab plus carboplatin/paclitaxel followed by durvalumab with or without olaparib in patients with mismatch repair proficient endometrial cancer: exploratory analyses of the DUO-E/GOG-3041/ENGOT-EN10 trial.

Journal: Gynecologic oncology

Published: November 28, 2025

Showing 1-12 of 135

Last Updated: 09/26/2026